Ablation for Hepatocellular Carcinoma: Where Do We Stand?

Affiliations

¹ Department of Medicine, Taipei Veterans General Hospital, Taipei, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan Department of Medicine, Taipei Veterans General Hospital, Taipei, Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan.

Comment

Po-Hong Liu et al. Ann Surg. 2017 Dec.

. 2017 Dec;266(6):e55-e56.

doi: 10.1097/SLA.0000000000001380.

¹ Department of Medicine, Taipei Veterans General Hospital, Taipei, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan Department of Medicine, Taipei Veterans General Hospital, Taipei, Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan.

No abstract available

Comment on

Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2 cm in a Propensity Score Model.
Liu PH, Hsu CY, Hsia CY, Lee YH, Huang YH, Chiou YY, Lin HC, Huo TI. Liu PH, et al. Ann Surg. 2016 Mar;263(3):538-45. doi: 10.1097/SLA.0000000000001178. Ann Surg. 2016. PMID: 25775062
Does Surgical Resection Provide Better Outcomes Than Radiofrequency Ablation in Patients With BCLC Very Early-stage Hepatocellular Carcinoma?
Li C, Wen TF. Li C, et al. Ann Surg. 2017 Dec;266(6):e54-e55. doi: 10.1097/SLA.0000000000001357. Ann Surg. 2017. PMID: 29136964 No abstract available.